Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. coronavirus sars
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Coronavirus Sars Articles & Analysis

11 news found

(Viral) Vaccine Manufacturing

(Viral) Vaccine Manufacturing

It is well accepted that vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like bacteria or viruses, which then keeps humans safe from the diseases they cause. Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...

ByNuvonis


Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on developing cost-effective, rapid, ...

ByBluejay Diagnostics, Inc.


POP BIO awarded $599,981 Phase 1 SBIR Award to Develop Thermostable COVID-19 Vaccine

POP BIO awarded $599,981 Phase 1 SBIR Award to Develop Thermostable COVID-19 Vaccine

BUFFALO, N.Y. — POP Biotechnologies Inc. (POP BIO) received a $599,981, two-year Phase I Small Business Innovation Research (SBIR) under Award No. 1R43AI165089-01, supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to pursue development of a potentially life-saving vaccine technology to address the ongoing ...

ByPOP Biotechnologies, Inc. (POP BIO)


Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential

Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential

Four-year agreement with Bill & Melinda Gates Foundation to discover and develop small molecule therapeutics with less susceptibility to variants and greater patient access than current approaches -- Exscientia to use leading AI platform and in-house drug expertise to discover and develop five phase 1-ready assets; Gates Foundation to contribute sector expertise in antivirals and global ...

ByExscientia


EPA Announces Approval of Extensions to August 24, 2020, First-Ever Long-Lasting Antiviral Product for Use against COVID-19

EPA Announces Approval of Extensions to August 24, 2020, First-Ever Long-Lasting Antiviral Product for Use against COVID-19

On January 19, 2021, the U.S. Environmental Protection Agency (EPA) announced the issuance of a Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Section 18 emergency exemption to the states of Oklahoma and Arkansas, permitting American Airlines to use SurfaceWise2, believed to inactivate coronaviruses like the SARS-CoV-2 virus on surfaces, in specific airport facilities and planes. ...

ByBergeson & Campbell, P.C.


CoapTech PUG System Study For Safer Procedure Performance On COVID-Positive Patients

CoapTech PUG System Study For Safer Procedure Performance On COVID-Positive Patients

The novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to infect naïve populations causing surges of critically ill patients who can survive their acute critical illness. Tracheostomy and gastrostomy are commonly paired procedures that bridge patients from their acute to subacute critical illness. Both are aerosolgenerating procedures that can ...

ByCoapTech


Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test

Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test

Kephera Diagnostics announced today that it has been awarded a two-year, $1,989,300 Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), to complete the development and launch of a new test for Zika virus infection. Kephera’s test is aimed at detecting Zika ...

ByKephera Diagnostics, LLC


EPA Issues Stop Sale, Use, or Removal Orders to Amazon and eBay for Unregistered and Misbranded Pesticides and Devices, Including Products with Claims Related to COVID-19

EPA Issues Stop Sale, Use, or Removal Orders to Amazon and eBay for Unregistered and Misbranded Pesticides and Devices, Including Products with Claims Related to COVID-19

On June 11, 2020, the U.S. Environmental Protection Agency (EPA) announced in a press release that it issued stop sale, use, or removal orders (SSURO) to Amazon.com Services LLC (Amazon) and eBay, Inc. (eBay) for selling certain pesticide products that EPA claims are unregistered, misbranded, or restricted-use pesticides, and pesticide devices that EPA asserts make false or misleading claims. ...

ByBergeson & Campbell, P.C.


Elsevier launches COVID-19 Healthcare Hub

Elsevier launches COVID-19 Healthcare Hub

Elsevier, a global leader in information analytics specializing in science and health, has launched a new resource to aid healthcare workers on the front lines of managing the novel coronavirus health crisis. The COVID-19 Healthcare Hub provides free access to toolkits, expert insights, research resources and COVID-19 guidelines. The Hub’s toolkits include evidence-based clinical ...

ByElsevier Inc.


ONSLAUGHT Disinfectant from Bad Axe Restoration Products Approved for Use in Fight against the SARS-CoV-2 Virus

ONSLAUGHT Disinfectant from Bad Axe Restoration Products Approved for Use in Fight against the SARS-CoV-2 Virus

With over 800,000 people across the globe, including approximately 170,000 residents of the United States, known to be infected with the novel coronavirus (SARS-CoV-2), the pandemic has tragically already resulted in the deaths of tens of thousands of people. It has also cost untold trillions of dollars to world economies as schools, universities, transportation services, businesses and ...

ByCochrane & Associates, LLC


EnviroChemie is taking the effects of the coronavirus pandemic seriously and is still here for you

EnviroChemie is taking the effects of the coronavirus pandemic seriously and is still here for you

The health of our employees, business partners and the general public are very important to us We are taking the global health crisis caused by the coronavirus (SARS-CoV-2) very seriously and are doing our bit to slow down the spread of the virus. We have informed our employees about protective measures and established rules for safe working within the team and also with business partners. This ...

ByEnviroChemie GmbH - part of the EnviroWater Group

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT